141 related articles for article (PubMed ID: 35491282)
1. Investigation of the diversity of human papillomavirus 16 variants and L1 antigenic regions relevant for the prevention of human papillomavirus-related oropharyngeal cancer in Japan.
Yoshida T; Ogawa T; Nakanome A; Ohkoshi A; Ishii R; Higashi K; Ishikawa T; Katori Y; Furukawa T
Auris Nasus Larynx; 2022 Dec; 49(6):1033-1041. PubMed ID: 35491282
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
Wang X; Han S; Li X; Wang X; Wang S; Ma L
Virol J; 2022 Mar; 19(1):37. PubMed ID: 35246180
[TBL] [Abstract][Full Text] [Related]
3. Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.
Oumeslakht L; Ababou M; Badaoui B; Qmichou Z
Gene; 2021 May; 782():145533. PubMed ID: 33636291
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
Lang Kuhs KA; Faden DL; Chen L; Smith DK; Pinheiro M; Wood CB; Davis S; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Wang X; Liu P; Mehrad M; Tucker T; Lewis JS; Ferris RL; Mirabello L
Ann Oncol; 2022 Jun; 33(6):638-648. PubMed ID: 35306154
[TBL] [Abstract][Full Text] [Related]
5. HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.
El Aliani A; El Abid H; Kassal Y; Khyatti M; Attaleb M; Ennaji MM; El Mzibri M
Gene; 2020 Jul; 747():144682. PubMed ID: 32304786
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.
Godi A; Vaghadia S; Cocuzza C; Miller E; Beddows S
Microbiol Spectr; 2022 Jun; 10(3):e0077922. PubMed ID: 35475682
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
[TBL] [Abstract][Full Text] [Related]
9. Characterization of major capsid protein (L1) variants of Human papillomavirus type 16 by cervical neoplastic status in Indian women: Phylogenetic and functional analysis.
Mane A; Patil L; Limaye S; Nirmalkar A; Kulkarni-Kale U
J Med Virol; 2020 Aug; 92(8):1303-1308. PubMed ID: 31944308
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
[TBL] [Abstract][Full Text] [Related]
11. Genetic signatures for lineage/sublineage classification of HPV16, 18, 52 and 58 variants.
Ou Z; Chen Z; Zhao Y; Lu H; Liu W; Li W; Ren P; Geng C; Xiao M; Hu G; Wu D; Wang X; Liu N; Zhu S; Lu L; Li J
Virology; 2021 Jan; 553():62-69. PubMed ID: 33238224
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
13. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
[TBL] [Abstract][Full Text] [Related]
15. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
16. High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.
Prétet JL; Dalstein V; Touzé A; Beby-Defaux A; Soussan P; Jacquin É; Birembaut P; Clavel C; Mougin C; Rousseau A; Lacau Saint Guily J;
Clin Exp Med; 2023 Feb; 23(1):87-96. PubMed ID: 35199231
[TBL] [Abstract][Full Text] [Related]
17. Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan.
Tanaka K; Kogure G; Onuki M; Matsumoto K; Iwata T; Aoki D; Kukimoto I
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336870
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Vaccine to End Oropharyngeal Cancer. A Systematic Review and Meta-Analysis.
Tsentemeidou A; Fyrmpas G; Stavrakas M; Vlachtsis K; Sotiriou E; Poutoglidis A; Tsetsos N
Sex Transm Dis; 2021 Sep; 48(9):700-707. PubMed ID: 34110733
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
Bettampadi D; Sirak BA; Abrahamsen ME; Reich RR; Villa LL; Ponce EL; Giuliano AR
Clin Infect Dis; 2021 Nov; 73(9):e3227-e3234. PubMed ID: 33173937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
